Asep Medical Holdings Inc (SEPSF)

USD 0.03

(0.0%)

Market Cap (In USD)

2.1 Million

Revenue (In USD)

21.14 Thousand

Net Income (In USD)

-8.22 Million

Avg. Volume

3321.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.0277-0.18214
PE
-
EPS
-
Beta Value
-2.26
ISIN
CA04368A1057
CUSIP
-
CIK
1969766
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Robert E. W. Hancock FRSC, OC, Ph.D.
Employee Count
-
Website
https://asepmedical.com
Ipo Date
2022-02-01
Details
Asep Medical Holdings Inc., through its subsidiary, ASEP Medical Inc. focuses on developing an early diagnostic tool for Sepsis and peptide therapeutic treatments for multiple applications. The company was formerly known as Trenchant Life Sciences Investment Corp. and changed its name to Asep Medical Holdings Inc. Asep Medical Holdings Inc. was incorporated in 2020 and is headquartered in Vancouver, Canada.